Global Bio-chem Technology Group Company Limited

大成生化科技集團有限公 司 *

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 00809) PROXY FORM Form of proxy for use by shareholders at the extraordinary general meeting to be convened at 11:00 a.m. on 22 September 2016 at Room 1, United Conference Centre, 10/F., United Centre, 95 Queensway, Admiralty, Hong Kong (or any adjournment thereof)

I/We (note a) of being the registered holder(s) of (note b) shares ("Shares") of HK$0.10 each in the capital of Global Bio-chem Technology Group Company Limited ("Company") hereby appoint the chairman of the extraordinary general meeting of the Company or of

to act as my/

our proxy (note c) at the extraordinary general meeting ("Meeting") to be held at 11:00 a.m. on 22 September 2016 at Room 1, United Conference Centre, 10/F., United Centre, 95 Queensway, Admiralty, Hong Kong, or at any adjournment thereof and to vote on my/our behalf as directed below.

Please make a mark in the appropriate boxes to indicate how you wish your vote(s) to be cast on a poll. (note d)

ORDINARY RESOLUTION (note e)

FOR

AGAINST

To approve the New Supplier Guarantees

Dated this day of 2016.

Shareholder's signature x x (notes f to k)

Notes:

  1. Full name(s) and address(es) are to be inserted in BLOCK CAPITAL LETTERS. The names of all joint registered holders should be stated.

  2. Please insert the number of Shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the Shares in the share capital of the Company registered in your name(s).

  3. A proxy need not be a member of the Company. If you wish to appoint some person other than the chairman of the Meeting as your proxy, please delete the words "the chairman of the extraordinary general meeting of the Company or" and insert the name and address of the person appointed in the space provided. A member of the Company entitled to attend and vote at the Meeting is entitled to appoint in written form one or, if he is the holder of two or more Shares, more proxies to attend and vote instead of him.

  4. If you wish to vote for any of the resolutions set out above, please tick ("") the boxes marked "For". If you wish to vote against any of the resolutions, please tick ("") the boxes marked "Against". If the form returned is duly signed but without specific direction on any of the proposed resolutions, the proxy will vote or abstain at his discretion in respect of all resolutions; or if in respect of a particular proposed resolution there is no specific direction, the proxy will, in relation to that particular proposed resolution, vote or abstain at his discretion.

  5. Please refer to the notice of the Meeting incorporated in the circular of the Company dated 6 September 2016 (the "Circular") for the full text of each of the resolutions. Unless otherwise stated, capitalized terms used in the Circular have the same meanings when used in this proxy form.

  6. In the case of joint holders of Shares, any one of such joint holders may vote, either in person or by proxy, in respect of such Share as if he/she were solely entitled thereto, but if more than one of such joint holders are present at the Meeting personally or by proxy, that one of the said persons so present whose name stands first on the register in respect of such share shall alone be entitled to vote in respect thereof.

  7. The form of proxy must be signed by a shareholder, or his attorney duly authorised in writing, or if the shareholder is a corporation, either under its Common Seal or under the hand of an officer or attorney so authorised.

  8. To be valid, this form of proxy together with any power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power or authority must be deposited at the offices of the Company's Hong Kong branch share registrar, Tricor Tengis Limited ("Registrar") of Level 22, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than 48 hours before the time fixed for holding of the Meeting or any adjournment thereof.

  9. For the purpose of determining members who are qualified for attending the extraordinary general meeting, the register of members of the Company will be closed on 22 September 2016, no transfer of the Shares will be effected on that day. In order to qualify for attending the extraordinary general meeting, all transfers of Shares accompanied by the relevant share certificates must be lodged with the Registrar at the above address by no later than 4:30 p.m. on 21 September 2016.

  10. Delivery of an instrument appointing a proxy should not preclude a member from attending and voting in person at the Meeting or any adjournment thereof and in such event, the instrument appointing a proxy shall be deemed to be revoked.

  11. Any alteration made to this form should be initialled by the person who signs the form.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy's (or proxies') name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the Meeting of the Company (the "Purposes"). We may transfer your and your proxy's (or proxies') name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorized by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy's (or proxies') name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to the Registrar at the above address.

* for identification purposes only

Global Bio-Chem Technology Group Co. Ltd. published this content on 06 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 September 2016 09:08:08 UTC.

Original documenthttp://www.globalbiochem.com/attachment/2016090616470100032611098_en.pdf

Public permalinkhttp://www.publicnow.com/view/523EFAC2E0F23ACA15199BBAF2FBE4BF1CA0B1EA